Tozasertib (Compound)

Synonyms:Tozasertib, 639089-54-6, VX-680, MK-0457, VX 680, MK 0457, VX680, VX-680 (MK-0457,Tozasertib), Tozasertib (VX-680), Tozasertib (USAN), Tozasertib [USAN], N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide, VX-68, MK-045, L-001281814, CHEMBL572878, 936915-58-1, N-(4-(4-(3-methyl-1H-pyrazol-5-ylamino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-ylthio)phenyl)cyclopropanecarboxamide, N-[4-({4-[(3-methyl-1H-pyrazol-5-yl)amino]-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide, N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide, VX6, 234335M86K, Cyclopropanecarboxamide, N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]-, Cyclopropanecarboxamide,N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]-, Cyclopropanecarboxylic Acid {4-[4-(4-Methyl-Piperazin-1-Yl)-6-(5-Methyl-2h-Pyrazol-3-Ylamino)-Pyrimidin-2-Ylsulfanyl]-Phenyl}-Amide, N-(4-((4-((5-methyl-1H-pyrazol-3-yl)amino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)thio)phenyl)cyclopropanecarboxamide, (N-[4({4-(4-methylpiperazin-1-yl)-6-[(3-methyl-1H-pyrazol-5 -yl)amino]pyrimidin-2-yl}thio)phenyl]cyclopropanecarboxamide), Cyclopropanecarboxamide, N-(4-((4-(4-methyl-1-piperazinyl)-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)thio)phenyl)-, N-(4-((4-(4-Methylpiperazin-1-yl)-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)sulfanyl)phenyl)cyclopropanecarboxamide, Tozasertib [USAN:INN], UNII-234335M86K, N-[4-({4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide, VE 465, VX-680 (MK-0457, Tozasertib), Kinome_3803, 2f4j, TOZASERTIB [INN], Tozasertib (MK-0457), TOZASERTIB [WHO-DD], Cyclopropanecarboxylic acid N-(4-((4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-yl)sulfanyl)phenyl)amide, MLS001065920, SCHEMBL614528, GTPL5718, BDBM13534, CHEBI:91336, DTXSID10213609, BCPP000017, HMS2043N07, HMS2198F22, HMS3244O19, HMS3244O20, HMS3244P19, HMS3265C21, HMS3265C22, HMS3265D21, HMS3265D22, HMS3654I11, HMS3750O19, ACT03970, BCP01859, EX-A2179, Tozasertib(MK-0457,VX-680), BDBM50004205, MFCD13185152, NSC745967, NSC800955, s1048, VX-680; Tozasertib; MK-0457, AKOS015902930, CCG-264793, CS-0007, NSC-745967, NSC-800955, SB19302, Tozasertib (VX-680, MK-0457), VX-680 (Tozasertib, MK-0457), VX-680 - MK0457 - Tozasertib, NCGC00168110-01, NCGC00168110-02, NCGC00168110-05, AM808097, AS-18632, Cyclopropane carboxylic acid{4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidin-2-ylsulphanyl]-phenyl}-amide, HY-10161, SMR000486395, VX-680, MK-0457, TOZASERTIB, FT-0652724, SW212828-2, EC-000.2365, A19417, D08279, EN300-6743235, J-523024, Q6605919, BRD-K59369769-001-02-1, BRD-K59369769-001-09-6, BRD-K59369769-001-12-0, BRD-K59369769-001-14-6, BRD-K87947369-001-01-6, cyclopropane carboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2h-pyrazol-3-ylamino)-pyrimidin-2-ylsulphanyl]-phenyl}-amide, cyclopropane carboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidin-2ylsulphanyl]-phenyl}-amide, cyclopropane carboxylic acid(4-(4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-ylsulfanyl)phenyl)amide, Cyclopropanecarboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-1H-pyrazol-3-ylamino)-pyrimidin-2, N-[4-[[4-(4-methylpiperazino)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]thio]phenyl]cyclopropanecarboxamide

Id:5494449

Description:nan